Researchers from Rutgers believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—an antiviral medication that helps keep high-risk patients out of the hospital.
Mar 28, 2024
0
1
A rising number of measles cases in the U.S. this year is raising concerns over a comeback of a disease that was declared eliminated in this country 24 years ago.
Apr 15, 2024
0
0
Adults younger than 35 to 45 years old may have a higher risk of developing a stroke from nontraditional risk factors such as migraines than from traditional risks like high blood pressure. That's according to new research ...
Mar 26, 2024
0
1
Eating more dietary fiber may help prevent type 2 diabetes by promoting beneficial gut bacteria and substances produced during metabolism, according to new research in Hispanic adults.
Mar 29, 2024
0
3
A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using molnupiravir to treat COVID-19.
Apr 8, 2024
0
45
Recent research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented by ...
Apr 10, 2024
0
5
Could taking statins benefit your mouth in addition to your arteries? A new study conducted in cell cultures has shown that cholesterol-lowering drugs help to dampen the inflammation associated with periodontal disease by ...
Mar 25, 2024
0
23
Smallpox, a disease that killed an estimated 500 million people in the 20th century alone, is the only human disease to be eradicated. However, a new report, "Future State of Smallpox Medical Countermeasures," from the National ...
Apr 13, 2024
0
8
A new study that models the combined effects of a sugar-based tax on beverages and targeted subsidies for minimally processed foods and drinks has found that under these policies, low-income consumers would purchase fewer ...
Apr 2, 2024
1
75
A new meta-analysis shows sodium glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of major adverse cardiovascular events in patients with either diabetes at high risk of atherosclerotic cardiovascular disease (ASCVD), ...
Apr 8, 2024
0
0
